Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115219
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2005-06-21
Brief Title:
Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly BIW in Rheumatoid Arthritis RA Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly QW
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20040275
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None